Mise à jour, mars 2021

Ce document, qui fait l’objet de mises à jour régulières, fournit des perspectives factuelles sur les meilleures pratiques pour les ophtalmologistes au Canada. On peut le consulter comme un supplément au document publié par la SCO le 3 juin 2020, intitulé « Immediately Sequential Bilateral Cataract Surgery (ISBCS) – Key Points » (Annexe 1).

AVERTISSEMENT : Ce document ne doit pas être considéré comme préconisant une adoption généralisée de la CCBIS; cependant, si des individus ou des groupes l’envisagent ou débutent cette pratique dans le contexte de la pandémie de COVID-19, nous espérons que les perspectives offertes seront utiles. Il sera important que ceux qui pratiquent la CCBIS suivent les recommandations sur les meilleures pratiques afin d’optimiser les résultats et de minimiser le risque de complications. Il importe également de noter que les normes de la CCBIS et les restrictions dues à la COVID évoluent et que tous les chirurgiens doivent rester informés et faire preuve de discernement et de jugement clinique lorsqu’ils décident des meilleurs soins pour leurs patients.

Détails d’accès

Lire l’intégralité du document, chirurgie de la cataracte bilatérale immédiatement séquentielle (CCBIS) Considérations relatives à la COVID-19

L’édition actuelle de la trousse à outils contient des informations sur les sujets suivants :

• À propos de la COVID-19
• Aperçu des vaccins
• Vaccins autorisés
• Orientations à l’intention des fournisseurs de soins de santé
• Sécurité des vaccins
• Ressources supplémentaires

Détails d’accès

Trousse à outils de vaccination pour les fournisseurs de soins de santé.

December, 2020

Guidelines for the Cleaning and Sterilization of Intraocular Surgical Instruments

These guidelines are intended to assist ambulatory surgery centers (ASCs) in their efforts to adopt appropriate practices for the cleaning and sterilization of intraocular surgical instruments. They are provided for scientific, educational, and informational purposes only. They are not intended to establish the only acceptable or appropriate standards, methods, or practices for cleaning and sterilizing such instruments. Adherence to these guidelines does not guarantee compliance with any legal or regulatory standards, including without limitation the criteria for ASC licensure or certification, or Medicare or other third-party payer reimbursement. In addition, any discussion or recommendation in these guidelines regarding the use of drugs or devices that deviate from the U.S. Food and Drug Administration (FDA)–approved use of such product (ie, an “off-label use”) is made for scientific and educational purposes only and intended to fall within the FDA’s “practice of medicine” exception for off-label uses. Individual physicians must make independent judgments as to whether the off-label use of a particular drug or device is appropriate and in the patient’s best interest based on the facts and circumstances of the particular case.

Access Details

Download the full OICS Guidelines in English.

November, 2020

This guide is designed for policy-makers, public health leaders and senior clinicians involved in planning, designing and implementing diabetic retinopathy screening programmes in the WHO European Region. The purpose of screening is to identify people with diabetes who are at higher risk of developing sight-threatening diabetic retinopathy so that early treatment or intervention can be offered to reduce the incidence of vision impairment or blindness. It demonstrates how the Wilson & Jungner principles apply to diabetic retinopathy screening, describes the pathway to follow and explains how to initiate new programmes or improve the effectiveness of those already existing. The guide forms part of WHO’s efforts to increase the effectiveness of screening programmes within the Region, maximizing benefits and minimizing harm.

Access details

Download the full guide in English (PDF, ‎1.632 MB)

This program was developed under the leadership of a multi-disciplinary steering committee, chaired by Dr. David Wong, ophthalmologist and Dr. Peter Lin, Family Physician. Steering committee members include Dr. Bernard Hurley and Dr. David Maberley (ophthalmologists), Dr. John Axler and Dr. Carl Fournier (family physicians), and Dr. Alice Cheng (endocrinologist).

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ credits. The initiative was supported in part by an educational grant from Bayer.

• English: www.diabetesandtheeyes.com

• French: www.lediabeteetlesyeux.com

This program will reinforce the importance of primary care providers in the care of the eye of patients with diabetes. An overview is provided on the ways in which primary care providers can help close the current screening and care gap for diabetic eye disease here in Canada. Participants will understand the consequences of delays in screening and they will be introduced to a practical tool developed by COS which will help encourage eye screening in people with diabetes. To help to reduce eye complications due to diabetes, the session will also emphasize the importance of good diabetes care in general.

Program Learning Objectives:

• Describe the importance of retinopathy in patients with diabetes
• Define macular edema, and proliferative and non-proliferative retinopathy
• Recognize how to screen for these conditions
• Summarize the current treatment options for our patients

CPD Credits
This Self-Learningprogram has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ credits

Patient Brochure

Access Details

• English: www.diabetesandtheeyes.com

• French: www.lediabeteetlesyeux.com

24 August, 2020

COVID-19 – Preliminary Clinical Guidelines for Ophthalmology Practices

Authors: Reza Gharebaghi,Jordan Desuatels,Majid Moshirfar, Maryam Parvizi,Seyed-Hashem Daryabari, and Fatemeh Heidary

Abstract

The zoonotic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its resultant human coronavirus disease (COVID-19) recently appeared as a global health threat that can cause severe respiratory infection and terminal respiratory distress. By the first week of April, more than 1.3 million people had been globally infected and more than 70,000 had lost their lives to this contagious virus.

Clinical manifestations occur shortly after exposure, or a few days later. There is controversy regarding the transmission of the virus through the tear and conjunctiva; however, there are reports that the ocular surface might be a potential target for COVID-19. The ease of transmission of this virus at close proximity presents a risk to eyecare workers. Several recommendations have been issued by local and national organizations to address the issue of safe ophthalmic practice during the ongoing COVID-19 pandemic. These guidelines have numerous similarities; however, subtle differences exist. The purpose of this paper was to discuss measures, with a specific focus on standard precautions, to prevent further dissemination of COVID-19 at Eye Clinics. We have proposed procedures to triage suspected cases of COVID-19, considering emergency conditions.

Access Details:

Read the full article COVID-19: Preliminary Clinical Guidelines for Ophthalmology Practices here

August 11, 2020

COVID-19 and the Ophthalmology Match
David A. Quillen, MD – Hershey, Pennsylvania
R. Michael Siatkowski, MD – Oklahoma City, Oklahoma
Steven Feldon, MD, MBA – Rochester, New York, on behalf of the Association of University Professors of
Ophthalmology

The coronavirus disease 2019 (COVID-19) pandemic has impacted ophthalmology and medical education profoundly. In an effort to reduce the transmission of severe acute respiratory syndrome coronavirus 2, the American Academy of Ophthalmology issued a statement on March 18, 2020,urging all ophthalmologists immediately to cease providing any treatment other than urgent or emergent care.1 This recommendations endorsed by every major ophthalmology organization in the United States resulted in a 79% reduction in care, the highest decline of any medical or surgical discipline.2 Concurrently, the Association of American Medical Colleges recommended that medical schools pause all medical student clinical rotations and suggested that medical students not be involved in any direct patient care.3 The disruption was unprecedented. Medical students were unable to complete core clerkship and specialty electives at a critical time in their training. Imposed travel restrictions limited their ability to pursue rotations away from their home institutions (“away rotations”), global health experiences, and academic meetings. Social distancing requirements interrupted research activities and prevented some medical students from completing the United States Medical Licensing Examinations (USMLEs).

Read the Full Editorial, COVID-19 and the Ophthalmology Match Editorial here.

July 20, 2020

This guidance has been developed by the RCOphth COVID-19 Review Team and the UK and Ireland Society of Cataract and Refractive Surgeons (UKISCRS) in response to the pandemic and may be subject to change.

We are facing significant capacity challenges brought about by the COVID pandemic. We need to restore surgery for the visual rehabilitation of cataract patients as well as maintain safe practice in the prevention of COVID transmission. One avenue being considered by some units for mitigating risks associated with multiple visits and to optimise and streamline services is the use of bilateral sequential cataract surgery (referred to by NICE as “bilateral simultaneous” surgery), that is the second eye surgery is performed immediately after the first eye surgery on the same list.

Read the Full RCOphth/UKISCRS rapid advice document guidance document on ISBCS here.

Mise à jour – 9 juin 2020

La pandémie de COVID-19 a entraîné l’application généralisée de mesures d’éloignement physique et l’arrêt des visites et interventions médicales non urgentes. De nombreuses provinces et autorités sanitaires sont en train d’assouplir ces mesures. Le présent document a pour but de fournir des conseils aux médecins qui s’occupent de patients atteints de glaucome afin de contribuer à atténuer le risque, à la fois pour eux et pour les fournisseurs de soins, tout en conciliant la nécessité d’un traitement pour préserver la vision. Il convient de recommencer à voir les cas non urgents et de routine dans les régions où les autorités sanitaires ont assoupli les politiques d’isolement. Comme la crise sanitaire évolue rapidement, ces recommandations peuvent être modifiées, et nous demandons instamment à tous les cliniciens de faire preuve de jugement quant aux soins qu’ils prodiguent aux patients et de tenir compte des bonnes pratiques. Ces recommandations sont basées sur les Lignes directrices de la SCO et de l’ACUPO pour les soins en ophtalmologie durant la pandémie de COVID-19, du 20 mars 2020, les Recommandations de la Société canadienne du glaucome pour la prestation de soins oculovisuels aux patients atteints de glaucome pendant la pandémie de COVID-19 en date du 16 avril 2020, la Liste de vérification pour la réouverture des cliniques d’ophtalmologie pendant la COVID-19 datée du 12 mai 2020, les lignes directrices de l’American Academy of Ophthalmology et les United Kingdom National Health Society guidelines.

Lisez la version intégrale des Recommandations de la Société canadienne de glaucome pour la fourniture de soins oculaires aux patients atteints de glaucome pendant la pandémie de COVID-19.